Kintara Therapeutics, Inc. (KTRA) Financials

KTRA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 1.9 million 2.0 million
2023-09-30 1.5 million 3.5 million
2023-06-30 4.0 million 3.2 million
2023-03-31 6.7 million 3.0 million

KTRA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -2.1 million 165000
2023-09-30 -1.3 million 160000
2023-06-30 -1.5 million 246000
2023-03-31 -1.8 million 290000

KTRA Net Income

No data available :(

KTRA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 658000 - -
2023-09-30 216000 - -
2023-06-30 1.5 million - -
2023-03-31 3.0 million - -

KTRA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 4.3 million
2023-09-30 1.7 million
2023-06-30 1.7 million
2023-03-31 1.7 million

KTRA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 20000 111000 908000 15000
2023-09-30 - 1.9 million 1.1 million -
2023-06-30 - 2.1 million 1.3 million -
2023-03-31 - 2.0 million 1.3 million -

KTRA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 15000
2023-09-30 - 15000
2023-06-30 - 15000
2023-03-31 - 15000

KTRA

Price: $0.14

52 week price:
0.08
5.60

Earnings Per Share: -5.22 USD

P/E Ratio: -0.01

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 62500

Market Capitalization: 5.8 million

Links: